Foulis man shot during robbery

first_imgA Foulis, East Coast Demerara man is currently hospitalised and nursing a gunshot wound to his shoulder, after three armed bandits pounced on him and his employer upon their return from the bank.Injured is 37-year-old Lukpaul Sukhai of Foulis Housing Scheme. According to reports, the incident occurred sometime around 15:00h on Friday.Guyana Times understands that Sukhai and his employer went to a city bank earlier in the day to withdraw money and then went to Camp Street, where from there the men drove back to Foulis, unaware that they were being followed.When they arrived in front of the contractor’s house, his wife and a relative came out and opened the gate. At that point, a white 212 Toyota motor car rushed up in front of the house and two men, one of whom was armed with handgun, immediately exited.The armed man then discharged a round at Sukhai, hitting him in his right shoulder. After being shot, and with his employer still in the car, the injured man drove away from house. The bandits then turned their attention to the businessman’s wife and the relative, Sumal Budhnarine.At the time, Budhnarine, 23, also of Foulis Housing Scheme, had a haversack which contained ,000 and three women’s top. The two bandits snatch the bag and rushed back into the car, where they had a third accomplice who drove them away.The injured Sukhai was rushed to the Georgetown Public Hospital where he has been admitted a patient. Even with a bullet lodged in his shoulder, the 37-year-old man is listed as stable.The Police have since launched an investigation into the robbery. No arrest has been made.last_img read more

Stem Cell News: Adults Still Lead

first_imgStem cells are still hot.  Most of the significant findings are coming from adult stem cells (AS) or induced pluripotent stem cells (iPS) rather than embryonic stem cells (ES).  For example, a PhysOrg article described progress at the University of Michigan in predicting what cell types stem cells will become.  Nothing was said in the article about embryonic stem cells.  Here are more news reports since the 07/20/2010 entry on the lead of adult stem cell discoveries over ES findings.    RNA is a rising star in stem cell research.  For instance, according to Science Daily, Caltech found that micro-RNAs, once of unknown function or considered cellular junk, are intimately involved with stem cells.  It appears they control the function of mammalian stem cells in the blood, determining what types of blood cell they will become.  Similarly, PhysOrg reported on work at Massachusetts General Hospital that found micro RNAs are involved in controlling the number of blood cells in the body.  Science Daily reported on work at MIT that finds RNA provides a safer way to reprogram stem cells (iPS cells).     Research at Stanford found that purifying the stem cells from bone marrow increase the chances for successful bone marrow transplants, according to PhysOrg.  Adult stem cells continue to show promise for healing broken hearts.  According to PhysOrg mesenchymal stem cells injected into pigs with heart disease made their hearts “good as new.”  Want a renewed, all-natural joint?  PhysOrg reported that adult stem cells are coming along well in experiments.  It appears from tests on rabbits that “failing joints can be replaced with a joint grown naturally using the host’s own stem cells.”  Researchers foresee a future with “naturally grown joints that would last longer than currently used artificial joints.”  Another study announced by PhysOrg found that, for patients with deadly brain tumors called glioblastomas, survival time was doubled if radiation therapy was directed at parts of the brain known to harbor stem cells that perhaps had become cancerous.  The radiation apparently targets the source of proliferating cancer cells.    Overall, PhysOrg reported, adult stem cell therapies are “far ahead” of embryonic experiments.  “For all the emotional debate that began about a decade ago on allowing the use of embryonic stem cells,” the article said, “it’s adult stem cells that are in human testing today.  An extensive review of stem cell projects and interviews with two dozen experts reveal a wide range of potential treatments.”  The score for ES cells is still zero.  While according to New Scientist the first embryonic stem cell test on humans has gotten a green light, PhysOrg said that “in the near term, embryonic stem cells are more likely to pay off as lab tools, for learning about the roots of disease and screening potential drugs,”  An ethicist quoted in the article, however, dubbed all the efforts for a decade to use ES cells for therapy as “fruitless.”    But perhaps the most significant news was announced by Science Daily.  The Whitehead Institute for Biomedical Research has added strong evidence that ES and iPS stem cells are “virtually identical,” apparently removing any need for embryonic stem cells with their “ethical hurdles.”  Garrett Frampton, co-author of a paper in Cell Stem Cell about this comparison, commented, “Billions of dollars have been invested in the idea that we will use ES cells at some point in the future as therapeutic or regenerative agents, but for ethical and practical issues, this may not be possible.  But if they work out therapies with ES cells, and iPS cells are equivalent to ES cells, then the idea is that those therapies could be used with iPS cells as well.”    In light of this scorecard, why was the dominant theme in the past decade focused on the promise of embryonic stem cells?  PhysOrg reported on a study at the University of Arizona that found who drove the issue.  It wasn’t public demand.  It wasn’t even the media.  According to the study, President Bush had little influence holding back the tide of ES research because of the demands of scientific elites.  The scientific community held the ball on the issue, and the media followed them – not the President.  “They also found that while two-thirds of the sources included in the stories were ‘elites,’ such as experts and politicians, not one story used the president as a dominant source.”  When President Obama voiced support for ES research, that all changed.  The media, the scientific community and the President were then all on the same team.  One of the study authors remarked, “I think it is time for us to see whether the same pattern occurred during the debate for health care reform under the new Obama administration.”Defend science.  But when a scientist (or reporter, or President, or any other human being) does something deplorable, loses integrity, promotes a selfish agenda, wastes money, runs roughshod over ethics, or abandons common sense, “science” makes a pitiful shield.(Visited 6 times, 1 visits today)FacebookTwitterPinterestSave分享0last_img read more

SOA + BPM: EAI evolves

first_imgAcronym and lovers of jargon have celebrated a pleasant holiday.  A new Forrester Wave study that came out just before Christmas created new BPM-space acronyms.  Forrester now divides BPM into two halves: IC-BPMS (Integration-Centric Business Process Management Suite) and HC-BPMS (Human-Centric Business Process Management Suite) . Other than the convoluted names, the study has some valuable information, and the report has been made available free by a number of vendors who placed well among the thirteen companies covered, like webMethods.Forrester had previously covered a space called “integration suite” representing products with Enterprise Application Integration (EAI) capabilities, but they found that the introduction of SOA technology has changed the space.  EAI has now evolved into IC-BPMS. Part of the reason for the switch in naming is that they think that product offerings over just the last 4-5 years have changed dramatically.  Vendor offerings that had been closed and proprietary are now standards-based, and most vendors have also augmented their products to include embedded Enterprise Service Bus (ESB) and enhanced Business Process Management (BPM) capabilities.The Forrester study looked at 85 different criteria and found that webMethods, TIBCO Software, IBM, and Sun were the category leaders, based on their strengths in connection, BPM and SOA.IC-BPMS products allow composite applications to be constructed using model-based tools and to blend structured, unstructured and metadata stored in SOA-based registries and repositories.  The tools in the category promote reusability of all system components: services, code and data.HC-BPMS products have their origins with workflow and imaging and typically involve intensive human interaction.The report emphasizes a synergy and overlap between capabilities in BPM and SOA and suggest that companies should try to achieve the benefits of both with new implementations.webMethods was considered the leader in this category, although it is the smallest of the top-ranked vendors.  Somewhat of a surprise, Sun ranked well too because of their 2005 acquisition of SeeBeyond Technologies, a company with a J2EE-based solution.last_img read more